Immediate Impact

60 standout
Sub-graph 1 of 23

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
2 intermediate papers

Works of Mark Puhlman being referenced

Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes
2002

Author Peers

Author Last Decade Papers Cites
Mark Puhlman 88 73 53 60 8 172
Angela Delsing 128 28 20 77 6 272
Thomas Signouret 40 44 61 118 7 254
Brian Buxton 136 40 46 158 10 262
Ezio Micalizzi 70 24 57 80 10 196
Haruka Kimura 94 55 51 134 14 228
Anna Hall 98 26 51 47 6 192
Anne Lesage 44 15 37 42 7 156
O. Thuemer 167 53 21 106 10 273
L. Cubattoli 93 33 13 76 11 133
Luigi Vecchi 39 30 9 69 11 188

All Works

Loading papers...

Rankless by CCL
2026